Evidence map›Paper›PMID 31061539›Full record

ReviewNature medicine2019

The pros, cons, and many unknowns of probiotics.

Jotham Suez, Niv Zmora, Eran Segal, Eran Elinav

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 758 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
758citing papers in PubMed, 6 pooled it
112.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

758 citing papers in PubMed, 6 syntheses or guidelines pooled it, 1,310 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Nutrients · 2025
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Review
  19. Review
  20. Review

698 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jotham SuezImmunology Department, Weizmann Institute of Science, Rehovot, Israel.
Niv ZmoraImmunology Department, Weizmann Institute of Science, Rehovot, Israel.
Eran SegalDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. eran.segal@weizmann.ac.il.ORCID http://orcid.org/0000-0002-6859-1164
Eran ElinavImmunology Department, Weizmann Institute of Science, Rehovot, Israel. eran.elinav@weizmann.ac.il.ORCID http://orcid.org/0000-0002-5775-2110
Weizmann Institute of Science · ILGerman Cancer Research Center · DETel Aviv Sourasky Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consumption of over-the-counter probiotics for promotion of health and well-being has increased worldwide in recent years. However, although probiotic use has been greatly popularized among the general public, there are conflicting clinical results for many probiotic strains and formulations. Emerging insights from microbiome research enable an assessment of gut colonization by probiotics, strain-level activity, interactions with the indigenous microbiome, safety and impacts on the host, and allow the association of probiotics with physiological effects and potentially useful medical indications. In this Perspective, we highlight key advances, challenges and limitations in striving toward an unbiased interpretation of the large amount of data regarding over-the-counter probiotics, and propose avenues to improve the quality of evidence, transparency, public awareness and regulation of their use.

Indexed as

AnimalsClinical Trials as TopicClostridium InfectionsGastroenteritisGastrointestinal MicrobiomeHost Microbial InteractionsHumansImmunomodulationInfant, NewbornIrritable Bowel SyndromeNeonatal SepsisProbioticsRespiratory Tract InfectionsSafetyTreatment Outcome

Identifiers

PMID31061539
OpenAlexW2943320595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.